SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-035093
Filing Date
2023-07-19
Accepted
2023-07-18 21:13:06
Documents
15
Period of Report
2023-07-18
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc20056046_8k.htm   iXBRL 8-K 32065
2 EXHIBIT 5.1 brhc20056046_ex5-1.htm EX-5.1 14957
7 image00001.jpg GRAPHIC 2769
  Complete submission text file 0001140361-23-035093.txt   231772

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bngo-20230718.xsd EX-101.SCH 4327
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bngo-20230718_def.xml EX-101.DEF 17538
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bngo-20230718_lab.xml EX-101.LAB 27036
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bngo-20230718_pre.xml EX-101.PRE 19723
9 EXTRACTED XBRL INSTANCE DOCUMENT brhc20056046_8k_htm.xml XML 6220
Mailing Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 888-7600
Bionano Genomics, Inc. (Filer) CIK: 0001411690 (see all company filings)

IRS No.: 261756290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38613 | Film No.: 231095434
SIC: 3826 Laboratory Analytical Instruments